Nektar TherapeuticsNKTRNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-222.64%
↓ 12% vs avg
Percentile
P36
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-198.83%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -222.64% | -152.8% |
| 2024 | -88.08% | +67.3% |
| 2023 | -269.75% | +23.3% |
| 2022 | -351.82% | +22.4% |
| 2021 | -453.18% | -75.7% |
| 2020 | -257.87% | +22.8% |
| 2019 | -333.89% | -642.6% |
| 2018 | 61.53% | +545.3% |
| 2017 | -13.82% | +76.5% |
| 2016 | -58.79% | - |